Program of cell survival underlying human and experimental hibernating myocardium

Circulation Research

Volumn 95, Issue 4, 2004, Pages 433-440

  Depre, Christophe ^a   Kim, Song Jung ^a   John, Anna S ^b   Huang, Yanhong ^a   Rimoldi, Ornella E ^b,c   Pepper, John R ^b   Dreyfus, Gilles D ^b   Gaussin, Vinciane ^a   Pennell, Dudley J ^b   Vatner, Dorothy E ^a   Camici, Paolo G ^b,c   Vatner, Stephen F ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

Author keywords

Coronary artery disease; Gene expression; Hibernation; Ischemia; Stunning

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENOMICS; GLUCOSE METABOLISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; HUMAN CELL; MALE; MYOCARDIAL HIBERNATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STUNNED HEART MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; CELL SURVIVAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 1; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INHIBITOR OF APOPTOSIS PROTEINS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MODELS, ANIMAL; MONOSACCHARIDE TRANSPORT PROTEINS; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA, MESSENGER; SUS SCROFA; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4143081494     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000138301.42713.18     Document Type: Article

References (49)

1. Narula J, Haider N, Virmani R, DiSalvo T, Kolodgie F, Hajjar R, Schmidt U, Semigran M, Dec G, Khaw B. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
2. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara J, Quaini E, Di Loreto C, Beltrami C, Krajewski S, Reed J, Anversa P. Apoptosis in human failing heart. N Engl J Med. 1997;336:1131-1141.
3. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki L, Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol. 2001;280:H2726-H2731.
4. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest. 1975;56:978-985.
5. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
6. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72;V123-V135.
7. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for hibernating myocardium. J Am Coll Cardiol. 1986;8:1467-1470.
8. Heusch G. Hibernating myocardium. Physiol Rev. 1998;78:1055-1085.
9. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng W, Melin JA. Chronic myocardial hibernation in humans. From bedside to bench. Circulation. 1997;95:1961-1971.
10. Vanoverschelde J, Depre C, Gerber B, Borgers M, Wijns W, Robert A, Dion R, Melin J. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol. 2000;85:1432-1439.
11. Kalra D, Zoghbi W. Myocardial hibernation in coronary artery disease. Curr Atheroscler Rep. 2002;4:149-155.
12. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med. 1998;339:173-181.
13. Flameng W, Vanhaecke J, Van Belle H, Borgers M, De Beer L, Minten J. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans. J Am Coll Cardiol. 1987;9:1235-1242.
14. Ausma J, Thone F, Dispersyn GD, Flameng W, Vanoverschelde JL, Ramaekers FC, Borgers M. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem. 1998;186:159-168.
15. Depre C, Taegtmeyer H. Metabolic aspects of programmed cell survival and cell death in the heart. Cardiovasc Res. 2000;45:538-548.
16. Camici PG, Rimoldi OE. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res. 2003;57:302-311.
17. Camici PG, Wijns W, Borgers M, De Suva R, Ferrari R, Knuuti J, Lammertsma AA, Liedtke AJ, Paternostro G, Vatner SF. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation. 1997;96:3205-3214.
18. Luss H, Boknik P, Heusch G, Muller F, Neumann J, Schmitz W, Schulz R. Expression of calcium regulatory proteins in short-term hibernation and stunning in the in-situ porcine heart. Cardiovasc Res. 1998;37:606-617.
19. Fallavollita JA, Jacob S, Young RF, Canty JM, Jr. Regional alterations in SR Ca2+-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol. 1999;277: H1418-1428.
20. Luss H, Schafers M, Neumann J, Hammel D, Vahlhaus C, Baba HA, Janssen F, Scheid HH, Schober O, Breithardt G. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res. 2002;56:411-421.
21. Kalra DK, Zhu X, Ramchandani MK, Lawrie G, Reardon MJ, Lee-Jackson D, Winters WL, Sivasubramanian N, Mann DL, Zoghbi WA. Increased Myocardial Gene Expression of Tumor Necrosis Factor-(alpha) and Nitric Oxide Synthase-2: A Potential Mechanism for Depressed Myocardial Function in Hibernating Myocardium in Humans. Circulation. 2002;105:1537-1540.
22. Shan K, Bick RJ, Poindexter BJ, Nagueh SF, Shimoni S, Verani MS, Keng F, Reardon MJ, Letsou GV, Howell JF, Zoghbi WA. Altered Adrenergic Receptor Density in Myocardial Hibernation in Humans: A Possible Mechanism of Depressed Myocardial Function. Circulation. 2000;102:2599-2606.
23. Kim S, Peppas A, Hong S, Yang G, Huang Y, Diaz G, Sadoshima J, Vatner D, Vatner S. Persistent stunning induces myocardial hibernation and protection. Circ Res. 2003;92:1233-1239.
24. Depre C, Tomlinson JE, Kudej RK, Gaussin V, Thompson E, Kim SJ, Vatner DE, Topper JN, Vatner SF. Gene program for cardiac cell survival induced by transient ischemia in conscious pig. Proc Natl Acad Sci USA. 2001;98:9336-9341.
25. Holly T, Drincic A, Byun Y, Nakamura S, Haris K, Klocke F, Cryns V. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol. 1999;31:1709-1715.
26. Radford N, Fina M, Benjamin I, Moreadith R, Graves K, Zhao P, Gavva S, Wiethoff A, Sherry A, Malloy C, Williams R. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci USA. 1996;93:2339-2342.
27. Trost S, Omens J, Karlon W, Meyer M, Metsril R, Covell J, Dillmann W. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J Clin Invest. 1998;101:855-862.
28. Martin J, Metsril R, Hilal-Dandan R, Brunton L, Dillmann W. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation. 1997;96:4343-4348.
29. Depre C, Hase M, Gaussin V, Zajac A, Wang L, Hittinger L, Ghaleh B, Yu X, Kudej RK, Wagner T, Sadoshima J, Vatner SF. Hl 1 Kinase Is a Novel Mediator of Myocardial Hypertrophy In Vivo. Circ Res. 2002;91:1007-1014.
30. Williams R, Benjamin I. Protective responses in the ischemic myocardium. J Clin Invest. 2000;106:813-818.
31. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;16:1445-1453.
32. Marinho NV, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation. 1996;93:737-744.
33. Gerber BL, Fath-Ordoubadi F, Wijns W, Vanoverschelde JL, Knuuti MJ, Janier M, Melon P, Blanksma PK, Bol A, Bax JJ, Melin JA, Camici PG. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp. Eur Heart J. 2001;22:1691-1701.
34. Kaufmann P, Gnecchi-Ruscone T, Yap J, Rimoldi O, Camici P. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med. 1999;40:1848-1856.
35. Depre C, Shipley G, Chen W, Han Q, Doenst T, Moore M, Stepkowski S, Davies P, Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Medicine. 1998;4:1269-1275.
36. Geng Y, Ishikawa Y, Vatner D, Wagner T, Bishop S, Vatner S, Homey C. Apoptosis of cardiac myocytes in Gsα transgenic mice. Circ Res. 1999;84:34-42.
37. Elsasser A, Schleper M, Klovekorn WP, Cai WP, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, Scahper J. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
38. Diamond G, Forrester J, deLuz P, Wyatt H, HJ S. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978;95:204-209.
39. Rahimtoola S. The hibernating myocardium. Am Heart J. 1989;117:211-221.
40. Vanoverschelde J, Wijns W, Depre C, Essamri B, Heyndrickx G, Borgers M, Bol A, Melin J. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523.
41. Fallavolita JA, Perry BJ, Canty Jr JM. 18F-2-Deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. Circulation. 1997;95:1900-1909.
42. Schulz R, Guth B, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res. 1992;70:1282-1295.
43. Canty J, Fallavollita J. Chronic hibernation and chronic stunning: A continuum. J Nucl Cardiol. 2000;7:509-527.
44. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning? Circ Res. 1995;76:479-488.
45. Vogt A, Elsasser A, Nef H, Bode C, Kubler W, Schaper J. Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium. Mol Cell Biochem. 2003;242:101-107.
46. Kloner RA, Jennings RB. Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1. Circulation. 2001;104:2981-2989.
47. Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972-983.
48. Wang Y, Guo Y, Zhang SX, Wu W-J, Wang J, Bao W, Bolli R. Ischemic Preconditioning Upregulates Inducible Nitric Oxide Synthase in Cardiac Myocyte. J Mol Cell Cardiol. 2002;34:5-15.
49. Thomas SA, Fallavollita JA, Suzuki G, Borgers M, Canty JM, Jr. Dissociation of Regional Adaptations to Ischemia and Global Myolysis in an Accelerated Swine Model of Chronic Hibernating Myocardium. Circ Res. 2002;91:970-977.